nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—Homicidal ideation—Varenicline—nicotine dependence	0.0362	0.047	CcSEcCtD
Venlafaxine—Panic reaction—Varenicline—nicotine dependence	0.0226	0.0294	CcSEcCtD
Venlafaxine—Tramadol—OPRM1—nicotine dependence	0.0197	1	CrCbGaD
Venlafaxine—Pleurisy—Varenicline—nicotine dependence	0.0186	0.0242	CcSEcCtD
Venlafaxine—Facial paralysis—Varenicline—nicotine dependence	0.0143	0.0186	CcSEcCtD
Venlafaxine—Respiratory tract congestion—Varenicline—nicotine dependence	0.0124	0.0162	CcSEcCtD
Venlafaxine—Varicose vein—Varenicline—nicotine dependence	0.0122	0.0158	CcSEcCtD
Venlafaxine—Abnormal behaviour—Varenicline—nicotine dependence	0.0122	0.0158	CcSEcCtD
Venlafaxine—Coronary artery disease—Varenicline—nicotine dependence	0.0115	0.0149	CcSEcCtD
Venlafaxine—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0112	0.0531	CbGpPWpGaD
Venlafaxine—VIIth nerve paralysis—Varenicline—nicotine dependence	0.0111	0.0144	CcSEcCtD
Venlafaxine—Dysphoria—Varenicline—nicotine dependence	0.0105	0.0136	CcSEcCtD
Venlafaxine—Peripheral vascular disorder—Varenicline—nicotine dependence	0.00926	0.012	CcSEcCtD
Venlafaxine—Suicide—Varenicline—nicotine dependence	0.00875	0.0114	CcSEcCtD
Venlafaxine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00875	0.0114	CcSEcCtD
Venlafaxine—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00873	0.0415	CbGpPWpGaD
Venlafaxine—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00845	0.0402	CbGpPWpGaD
Venlafaxine—Night sweats—Varenicline—nicotine dependence	0.00841	0.0109	CcSEcCtD
Venlafaxine—Urine abnormality—Varenicline—nicotine dependence	0.0082	0.0107	CcSEcCtD
Venlafaxine—Hostility—Varenicline—nicotine dependence	0.0082	0.0107	CcSEcCtD
Venlafaxine—Sexual dysfunction—Varenicline—nicotine dependence	0.0081	0.0105	CcSEcCtD
Venlafaxine—Osteoporosis—Varenicline—nicotine dependence	0.0081	0.0105	CcSEcCtD
Venlafaxine—Sleep disturbance—Varenicline—nicotine dependence	0.0081	0.0105	CcSEcCtD
Venlafaxine—Suicide attempt—Varenicline—nicotine dependence	0.008	0.0104	CcSEcCtD
Venlafaxine—NPY1R—Peptide GPCRs—OPRM1—nicotine dependence	0.00792	0.0376	CbGpPWpGaD
Venlafaxine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00778	0.0369	CbGpPWpGaD
Venlafaxine—Completed suicide—Varenicline—nicotine dependence	0.00772	0.01	CcSEcCtD
Venlafaxine—Urine analysis abnormal—Varenicline—nicotine dependence	0.00772	0.01	CcSEcCtD
Venlafaxine—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00771	0.0366	CbGpPWpGaD
Venlafaxine—Vaginal discharge—Varenicline—nicotine dependence	0.00746	0.0097	CcSEcCtD
Venlafaxine—Libido increased—Varenicline—nicotine dependence	0.00746	0.0097	CcSEcCtD
Venlafaxine—NPY1R—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00745	0.0354	CbGpPWpGaD
Venlafaxine—Psoriasis—Varenicline—nicotine dependence	0.00722	0.00939	CcSEcCtD
Venlafaxine—Parosmia—Varenicline—nicotine dependence	0.007	0.0091	CcSEcCtD
Venlafaxine—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00693	0.0329	CbGpPWpGaD
Venlafaxine—Cyst—Varenicline—nicotine dependence	0.00679	0.00882	CcSEcCtD
Venlafaxine—Intestinal obstruction—Varenicline—nicotine dependence	0.00666	0.00865	CcSEcCtD
Venlafaxine—Menstrual disorder—Varenicline—nicotine dependence	0.00666	0.00865	CcSEcCtD
Venlafaxine—Paranoia—Varenicline—nicotine dependence	0.00666	0.00865	CcSEcCtD
Venlafaxine—Haematemesis—Varenicline—nicotine dependence	0.00654	0.00849	CcSEcCtD
Venlafaxine—Suicidal ideation—Varenicline—nicotine dependence	0.00647	0.00841	CcSEcCtD
Venlafaxine—Delusion—Varenicline—nicotine dependence	0.00642	0.00833	CcSEcCtD
Venlafaxine—Nystagmus—Varenicline—nicotine dependence	0.00636	0.00826	CcSEcCtD
Venlafaxine—Hyperlipidaemia—Varenicline—nicotine dependence	0.0063	0.00818	CcSEcCtD
Venlafaxine—Mania—Varenicline—nicotine dependence	0.00624	0.00811	CcSEcCtD
Venlafaxine—Menorrhagia—Varenicline—nicotine dependence	0.00613	0.00797	CcSEcCtD
Venlafaxine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00607	0.0288	CbGpPWpGaD
Venlafaxine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00603	0.00783	CcSEcCtD
Venlafaxine—Scotoma—Varenicline—nicotine dependence	0.00598	0.00777	CcSEcCtD
Venlafaxine—Gingivitis—Varenicline—nicotine dependence	0.00579	0.00752	CcSEcCtD
Venlafaxine—Mydriasis—Varenicline—nicotine dependence	0.00569	0.0074	CcSEcCtD
Venlafaxine—Nephrolithiasis—Varenicline—nicotine dependence	0.00565	0.00734	CcSEcCtD
Venlafaxine—Glycosuria—Varenicline—nicotine dependence	0.0056	0.00728	CcSEcCtD
Venlafaxine—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00524	0.0249	CbGpPWpGaD
Venlafaxine—Aggression—Varenicline—nicotine dependence	0.00517	0.00671	CcSEcCtD
Venlafaxine—Accidental injury—Varenicline—nicotine dependence	0.00513	0.00667	CcSEcCtD
Venlafaxine—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00503	0.00653	CcSEcCtD
Venlafaxine—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00503	0.00653	CcSEcCtD
Venlafaxine—Thinking abnormal—Varenicline—nicotine dependence	0.00496	0.00644	CcSEcCtD
Venlafaxine—Nocturia—Varenicline—nicotine dependence	0.00489	0.00636	CcSEcCtD
Venlafaxine—Leukocytosis—Varenicline—nicotine dependence	0.00483	0.00628	CcSEcCtD
Venlafaxine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00482	0.0229	CbGpPWpGaD
Venlafaxine—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00478	0.0227	CbGpPWpGaD
Venlafaxine—Coordination abnormal—Varenicline—nicotine dependence	0.00462	0.00601	CcSEcCtD
Venlafaxine—Blood pressure increased—Varenicline—nicotine dependence	0.00454	0.0059	CcSEcCtD
Venlafaxine—Pulmonary embolism—Varenicline—nicotine dependence	0.00454	0.0059	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—TAS2R16—nicotine dependence	0.00451	0.0214	CbGpPWpGaD
Venlafaxine—Abnormal dreams—Varenicline—nicotine dependence	0.00449	0.00583	CcSEcCtD
Venlafaxine—Hyperkalaemia—Varenicline—nicotine dependence	0.00446	0.0058	CcSEcCtD
Venlafaxine—Eructation—Varenicline—nicotine dependence	0.00446	0.0058	CcSEcCtD
Venlafaxine—Influenza like illness—Varenicline—nicotine dependence	0.00441	0.00573	CcSEcCtD
Venlafaxine—Salivary hypersecretion—Varenicline—nicotine dependence	0.00441	0.00573	CcSEcCtD
Venlafaxine—Nightmare—Varenicline—nicotine dependence	0.00438	0.0057	CcSEcCtD
Venlafaxine—Photophobia—Varenicline—nicotine dependence	0.00426	0.00554	CcSEcCtD
Venlafaxine—Dry eye—Varenicline—nicotine dependence	0.00419	0.00545	CcSEcCtD
Venlafaxine—Oesophagitis—Varenicline—nicotine dependence	0.00415	0.00539	CcSEcCtD
Venlafaxine—Mouth ulceration—Varenicline—nicotine dependence	0.00411	0.00533	CcSEcCtD
Venlafaxine—Urine output increased—Varenicline—nicotine dependence	0.00411	0.00533	CcSEcCtD
Venlafaxine—Hypertonia—Varenicline—nicotine dependence	0.00398	0.00517	CcSEcCtD
Venlafaxine—Mental disability—Varenicline—nicotine dependence	0.00394	0.00512	CcSEcCtD
Venlafaxine—Euphoric mood—Varenicline—nicotine dependence	0.0039	0.00507	CcSEcCtD
Venlafaxine—Lymphadenopathy—Varenicline—nicotine dependence	0.00386	0.00502	CcSEcCtD
Venlafaxine—Sleep disorder—Varenicline—nicotine dependence	0.00381	0.00495	CcSEcCtD
Venlafaxine—Diabetes mellitus—Varenicline—nicotine dependence	0.00379	0.00492	CcSEcCtD
Venlafaxine—Polyuria—Varenicline—nicotine dependence	0.00375	0.00488	CcSEcCtD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00372	0.0177	CbGpPWpGaD
Venlafaxine—Deafness—Varenicline—nicotine dependence	0.00368	0.00479	CcSEcCtD
Venlafaxine—Eczema—Varenicline—nicotine dependence	0.00367	0.00476	CcSEcCtD
Venlafaxine—Eye pain—Varenicline—nicotine dependence	0.00365	0.00474	CcSEcCtD
Venlafaxine—Injury—Varenicline—nicotine dependence	0.00359	0.00466	CcSEcCtD
Venlafaxine—Libido decreased—Varenicline—nicotine dependence	0.00355	0.00462	CcSEcCtD
Venlafaxine—Hot flush—Varenicline—nicotine dependence	0.00352	0.00458	CcSEcCtD
Venlafaxine—Amnesia—Varenicline—nicotine dependence	0.00351	0.00456	CcSEcCtD
Venlafaxine—Increased appetite—Varenicline—nicotine dependence	0.00351	0.00456	CcSEcCtD
Venlafaxine—Menopausal symptoms—Varenicline—nicotine dependence	0.00349	0.00454	CcSEcCtD
Venlafaxine—Atrial fibrillation—Varenicline—nicotine dependence	0.00348	0.00452	CcSEcCtD
Venlafaxine—Visual disturbance—Varenicline—nicotine dependence	0.00348	0.00452	CcSEcCtD
Venlafaxine—Thirst—Varenicline—nicotine dependence	0.00346	0.0045	CcSEcCtD
Venlafaxine—Arthritis—Varenicline—nicotine dependence	0.00339	0.00441	CcSEcCtD
Venlafaxine—Hypoglycaemia—Varenicline—nicotine dependence	0.00338	0.00439	CcSEcCtD
Venlafaxine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00336	0.00437	CcSEcCtD
Venlafaxine—Osteoarthritis—Varenicline—nicotine dependence	0.0033	0.00428	CcSEcCtD
Venlafaxine—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0033	0.00428	CcSEcCtD
Venlafaxine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00327	0.00425	CcSEcCtD
Venlafaxine—Migraine—Varenicline—nicotine dependence	0.00324	0.00421	CcSEcCtD
Venlafaxine—Affect lability—Varenicline—nicotine dependence	0.00324	0.00421	CcSEcCtD
Venlafaxine—Psychotic disorder—Varenicline—nicotine dependence	0.00322	0.00418	CcSEcCtD
Venlafaxine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00315	0.015	CbGpPWpGaD
Venlafaxine—Irritability—Varenicline—nicotine dependence	0.00315	0.00409	CcSEcCtD
Venlafaxine—NPY1R—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00314	0.0149	CbGpPWpGaD
Venlafaxine—Urinary retention—Varenicline—nicotine dependence	0.00313	0.00407	CcSEcCtD
Venlafaxine—Mood swings—Varenicline—nicotine dependence	0.00312	0.00406	CcSEcCtD
Venlafaxine—Liver function test abnormal—Varenicline—nicotine dependence	0.00304	0.00395	CcSEcCtD
Venlafaxine—Dry skin—Varenicline—nicotine dependence	0.00302	0.00393	CcSEcCtD
Venlafaxine—Hypokalaemia—Varenicline—nicotine dependence	0.003	0.0039	CcSEcCtD
Venlafaxine—Cramp muscle—Varenicline—nicotine dependence	0.00297	0.00386	CcSEcCtD
Venlafaxine—Gastritis—Varenicline—nicotine dependence	0.00292	0.00379	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00291	0.0138	CbGpPWpGaD
Venlafaxine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00288	0.0137	CbGpPWpGaD
Venlafaxine—Abdominal distension—Varenicline—nicotine dependence	0.00287	0.00373	CcSEcCtD
Venlafaxine—Dysphagia—Varenicline—nicotine dependence	0.00285	0.0037	CcSEcCtD
Venlafaxine—Asthma—Varenicline—nicotine dependence	0.00285	0.0037	CcSEcCtD
Venlafaxine—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00284	0.0135	CbGpPWpGaD
Venlafaxine—Angina pectoris—Varenicline—nicotine dependence	0.00277	0.00361	CcSEcCtD
Venlafaxine—Bronchitis—Varenicline—nicotine dependence	0.00274	0.00356	CcSEcCtD
Venlafaxine—Pollakiuria—Varenicline—nicotine dependence	0.00263	0.00342	CcSEcCtD
Venlafaxine—Erectile dysfunction—Varenicline—nicotine dependence	0.00262	0.00341	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Varenicline—nicotine dependence	0.0026	0.00338	CcSEcCtD
Venlafaxine—Weight increased—Varenicline—nicotine dependence	0.00259	0.00337	CcSEcCtD
Venlafaxine—Hyperglycaemia—Varenicline—nicotine dependence	0.00257	0.00334	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00255	0.0121	CbGpPWpGaD
Venlafaxine—Depression—Varenicline—nicotine dependence	0.00253	0.00329	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00252	0.00327	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Varenicline—nicotine dependence	0.0025	0.00325	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0025	0.0119	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0025	0.0119	CbGpPWpGaD
Venlafaxine—Myocardial infarction—Varenicline—nicotine dependence	0.00249	0.00323	CcSEcCtD
Venlafaxine—Stomatitis—Varenicline—nicotine dependence	0.00248	0.00322	CcSEcCtD
Venlafaxine—Conjunctivitis—Varenicline—nicotine dependence	0.00247	0.00321	CcSEcCtD
Venlafaxine—Epistaxis—Varenicline—nicotine dependence	0.0024	0.00311	CcSEcCtD
Venlafaxine—Sinusitis—Varenicline—nicotine dependence	0.00238	0.0031	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00238	0.0113	CbGpPWpGaD
Venlafaxine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00233	0.0111	CbGpPWpGaD
Venlafaxine—Bradycardia—Varenicline—nicotine dependence	0.00232	0.00302	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—TAS2R16—nicotine dependence	0.00232	0.011	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—DRD2—nicotine dependence	0.00227	0.0108	CbGpPWpGaD
Venlafaxine—Hallucination—Varenicline—nicotine dependence	0.00227	0.00295	CcSEcCtD
Venlafaxine—Hypoaesthesia—Varenicline—nicotine dependence	0.00227	0.00295	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00226	0.0107	CbGpPWpGaD
Venlafaxine—Visual impairment—Varenicline—nicotine dependence	0.0022	0.00285	CcSEcCtD
Venlafaxine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00218	0.0103	CbGpPWpGaD
Venlafaxine—Erythema multiforme—Varenicline—nicotine dependence	0.00216	0.0028	CcSEcCtD
Venlafaxine—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00215	0.0102	CbGpPWpGaD
Venlafaxine—Tinnitus—Varenicline—nicotine dependence	0.00213	0.00276	CcSEcCtD
Venlafaxine—Cardiac disorder—Varenicline—nicotine dependence	0.00212	0.00275	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00211	0.01	CbGpPWpGaD
Venlafaxine—Chills—Varenicline—nicotine dependence	0.00205	0.00266	CcSEcCtD
Venlafaxine—Arrhythmia—Varenicline—nicotine dependence	0.00204	0.00265	CcSEcCtD
Venlafaxine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.002	0.00951	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—FGD1—nicotine dependence	0.002	0.0095	CbGpPWpGaD
Venlafaxine—Erythema—Varenicline—nicotine dependence	0.00198	0.00258	CcSEcCtD
Venlafaxine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00198	0.00942	CbGpPWpGaD
Venlafaxine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00198	0.00938	CbGpPWpGaD
Venlafaxine—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00196	0.0093	CbGpPWpGaD
Venlafaxine—Flatulence—Varenicline—nicotine dependence	0.00196	0.00254	CcSEcCtD
Venlafaxine—Dysgeusia—Varenicline—nicotine dependence	0.00194	0.00253	CcSEcCtD
Venlafaxine—Back pain—Varenicline—nicotine dependence	0.00192	0.00249	CcSEcCtD
Venlafaxine—Muscle spasms—Varenicline—nicotine dependence	0.00191	0.00248	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—OPRM1—nicotine dependence	0.0019	0.00903	CbGpPWpGaD
Venlafaxine—Vision blurred—Varenicline—nicotine dependence	0.00187	0.00243	CcSEcCtD
Venlafaxine—Tremor—Varenicline—nicotine dependence	0.00186	0.00242	CcSEcCtD
Venlafaxine—Ill-defined disorder—Varenicline—nicotine dependence	0.00184	0.00239	CcSEcCtD
Venlafaxine—Anaemia—Varenicline—nicotine dependence	0.00183	0.00238	CcSEcCtD
Venlafaxine—Agitation—Varenicline—nicotine dependence	0.00182	0.00237	CcSEcCtD
Venlafaxine—SLC6A3—Neuronal System—CHRNB3—nicotine dependence	0.00182	0.00866	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—FGD1—nicotine dependence	0.00182	0.00863	CbGpPWpGaD
Venlafaxine—Angioedema—Varenicline—nicotine dependence	0.00181	0.00236	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00181	0.00858	CbGpPWpGaD
Venlafaxine—Malaise—Varenicline—nicotine dependence	0.00179	0.00233	CcSEcCtD
Venlafaxine—Vertigo—Varenicline—nicotine dependence	0.00178	0.00232	CcSEcCtD
Venlafaxine—Syncope—Varenicline—nicotine dependence	0.00178	0.00231	CcSEcCtD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00176	0.00838	CbGpPWpGaD
Venlafaxine—Palpitations—Varenicline—nicotine dependence	0.00175	0.00228	CcSEcCtD
Venlafaxine—Loss of consciousness—Varenicline—nicotine dependence	0.00174	0.00227	CcSEcCtD
Venlafaxine—Cough—Varenicline—nicotine dependence	0.00173	0.00225	CcSEcCtD
Venlafaxine—SLC6A3—Neuronal System—CHRNA6—nicotine dependence	0.00173	0.00821	CbGpPWpGaD
Venlafaxine—Convulsion—Varenicline—nicotine dependence	0.00172	0.00223	CcSEcCtD
Venlafaxine—Hypertension—Varenicline—nicotine dependence	0.00171	0.00223	CcSEcCtD
Venlafaxine—Arthralgia—Varenicline—nicotine dependence	0.00169	0.0022	CcSEcCtD
Venlafaxine—Chest pain—Varenicline—nicotine dependence	0.00169	0.0022	CcSEcCtD
Venlafaxine—Myalgia—Varenicline—nicotine dependence	0.00169	0.0022	CcSEcCtD
Venlafaxine—Anxiety—Varenicline—nicotine dependence	0.00168	0.00219	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00167	0.00793	CbGpPWpGaD
Venlafaxine—Discomfort—Varenicline—nicotine dependence	0.00167	0.00217	CcSEcCtD
Venlafaxine—Dry mouth—Varenicline—nicotine dependence	0.00165	0.00215	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00163	0.00775	CbGpPWpGaD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00162	0.00771	CbGpPWpGaD
Venlafaxine—Oedema—Varenicline—nicotine dependence	0.00162	0.0021	CcSEcCtD
Venlafaxine—Infection—Varenicline—nicotine dependence	0.00161	0.00209	CcSEcCtD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00161	0.00764	CbGpPWpGaD
Venlafaxine—Shock—Varenicline—nicotine dependence	0.00159	0.00207	CcSEcCtD
Venlafaxine—Thrombocytopenia—Varenicline—nicotine dependence	0.00159	0.00206	CcSEcCtD
Venlafaxine—Tachycardia—Varenicline—nicotine dependence	0.00158	0.00205	CcSEcCtD
Venlafaxine—Hyperhidrosis—Varenicline—nicotine dependence	0.00157	0.00203	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00156	0.00743	CbGpPWpGaD
Venlafaxine—Anorexia—Varenicline—nicotine dependence	0.00154	0.00201	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00152	0.0072	CbGpPWpGaD
Venlafaxine—Hypotension—Varenicline—nicotine dependence	0.00151	0.00197	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00148	0.00192	CcSEcCtD
Venlafaxine—Insomnia—Varenicline—nicotine dependence	0.00147	0.0019	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00145	0.0069	CbGpPWpGaD
Venlafaxine—Dyspnoea—Varenicline—nicotine dependence	0.00144	0.00188	CcSEcCtD
Venlafaxine—Somnolence—Varenicline—nicotine dependence	0.00144	0.00187	CcSEcCtD
Venlafaxine—Dyspepsia—Varenicline—nicotine dependence	0.00143	0.00185	CcSEcCtD
Venlafaxine—Decreased appetite—Varenicline—nicotine dependence	0.00141	0.00183	CcSEcCtD
Venlafaxine—Fatigue—Varenicline—nicotine dependence	0.0014	0.00181	CcSEcCtD
Venlafaxine—Constipation—Varenicline—nicotine dependence	0.00139	0.0018	CcSEcCtD
Venlafaxine—Pain—Varenicline—nicotine dependence	0.00139	0.0018	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—DRD2—nicotine dependence	0.00137	0.00653	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TAS2R16—nicotine dependence	0.00137	0.0065	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00136	0.00648	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Varenicline—nicotine dependence	0.00133	0.00173	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00132	0.00172	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00132	0.00625	CbGpPWpGaD
Venlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00131	0.00622	CbGpPWpGaD
Venlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00129	0.00613	CbGpPWpGaD
Venlafaxine—Urticaria—Varenicline—nicotine dependence	0.00129	0.00167	CcSEcCtD
Venlafaxine—Abdominal pain—Varenicline—nicotine dependence	0.00128	0.00166	CcSEcCtD
Venlafaxine—Body temperature increased—Varenicline—nicotine dependence	0.00128	0.00166	CcSEcCtD
Venlafaxine—SLC6A3—Neuronal System—GABRA4—nicotine dependence	0.00125	0.00593	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00124	0.00589	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00122	0.00581	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—CHRNB4—nicotine dependence	0.0012	0.00569	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Varenicline—nicotine dependence	0.00119	0.00155	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00118	0.00563	CbGpPWpGaD
Venlafaxine—Asthenia—Varenicline—nicotine dependence	0.00116	0.00151	CcSEcCtD
Venlafaxine—Pruritus—Varenicline—nicotine dependence	0.00115	0.00149	CcSEcCtD
Venlafaxine—SLC6A3—Neuronal System—CHRNA5—nicotine dependence	0.00111	0.00529	CbGpPWpGaD
Venlafaxine—Diarrhoea—Varenicline—nicotine dependence	0.00111	0.00144	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—OPRM1—nicotine dependence	0.00107	0.0051	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—FGD1—nicotine dependence	0.00107	0.0051	CbGpPWpGaD
Venlafaxine—Dizziness—Varenicline—nicotine dependence	0.00107	0.00139	CcSEcCtD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00106	0.00504	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00104	0.00495	CbGpPWpGaD
Venlafaxine—Vomiting—Varenicline—nicotine dependence	0.00103	0.00134	CcSEcCtD
Venlafaxine—Rash—Varenicline—nicotine dependence	0.00102	0.00133	CcSEcCtD
Venlafaxine—Dermatitis—Varenicline—nicotine dependence	0.00102	0.00133	CcSEcCtD
Venlafaxine—Headache—Varenicline—nicotine dependence	0.00101	0.00132	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—DRD2—nicotine dependence	0.00101	0.00479	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000994	0.00472	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—OPRM1—nicotine dependence	0.000976	0.00464	CbGpPWpGaD
Venlafaxine—Nausea—Varenicline—nicotine dependence	0.000962	0.00125	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—AKR1B10—nicotine dependence	0.000948	0.0045	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000947	0.0045	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000937	0.00445	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000924	0.00439	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000914	0.00434	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—CHRNA3—nicotine dependence	0.000908	0.00431	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000906	0.00431	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000862	0.00409	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000854	0.00406	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00085	0.00404	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000843	0.004	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—CHRNB2—nicotine dependence	0.000799	0.0038	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—DRD2—nicotine dependence	0.000777	0.00369	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000758	0.0036	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—CHRNA4—nicotine dependence	0.000726	0.00345	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—DRD2—nicotine dependence	0.000706	0.00335	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000672	0.00319	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—WASF2—nicotine dependence	0.000668	0.00317	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—WASF1—nicotine dependence	0.00064	0.00304	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000618	0.00293	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000598	0.00284	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—OPRM1—nicotine dependence	0.000577	0.00274	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000563	0.00268	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000556	0.00264	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—DRD2—nicotine dependence	0.000417	0.00198	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000334	0.00159	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000289	0.00137	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000212	0.00101	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.00016	0.000761	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000156	0.000743	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000147	0.0007	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000146	0.000694	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	9.64e-05	0.000458	CbGpPWpGaD
